A retrospective analysis of tolerance and outcomes of cutaneous malignant melanoma in patients receiving adjuvant interferon-alpha 2B: a community oncology perspective. [electronic resource]
- Journal of experimental therapeutics & oncology Sep 2017
- 91-96 p. digital
Publication Type: Journal Article
1359-4117
Adult Age Factors Aged Chemotherapy, Adjuvant Depression--epidemiology Fatigue--epidemiology Female Fever--epidemiology Humans Interferon alpha-2 Interferon-alpha--therapeutic use Male Melanoma--drug therapy Middle Aged Nausea--epidemiology Quality of Life Retrospective Studies Skin Neoplasms--drug therapy Melanoma, Cutaneous Malignant Assessment of Medication Adherence